JP2007516278A5 - - Google Patents

Download PDF

Info

Publication number
JP2007516278A5
JP2007516278A5 JP2006546881A JP2006546881A JP2007516278A5 JP 2007516278 A5 JP2007516278 A5 JP 2007516278A5 JP 2006546881 A JP2006546881 A JP 2006546881A JP 2006546881 A JP2006546881 A JP 2006546881A JP 2007516278 A5 JP2007516278 A5 JP 2007516278A5
Authority
JP
Japan
Prior art keywords
cisapride
pat
cns
moiety
unrestricted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006546881A
Other languages
English (en)
Japanese (ja)
Other versions
JP4740152B2 (ja
JP2007516278A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/NO2004/000399 external-priority patent/WO2005061483A2/en
Publication of JP2007516278A publication Critical patent/JP2007516278A/ja
Publication of JP2007516278A5 publication Critical patent/JP2007516278A5/ja
Application granted granted Critical
Publication of JP4740152B2 publication Critical patent/JP4740152B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2006546881A 2003-12-23 2004-12-23 末梢性５−ｈｔ受容体の修飾因子 Expired - Fee Related JP4740152B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA200301924 2003-12-23
DKPA200301924 2003-12-23
PCT/NO2004/000399 WO2005061483A2 (en) 2003-12-23 2004-12-23 Modulators of peripheral 5-ht receptors

Publications (3)

Publication Number Publication Date
JP2007516278A JP2007516278A (ja) 2007-06-21
JP2007516278A5 true JP2007516278A5 (https=) 2008-08-14
JP4740152B2 JP4740152B2 (ja) 2011-08-03

Family

ID=34707211

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006546881A Expired - Fee Related JP4740152B2 (ja) 2003-12-23 2004-12-23 末梢性５−ｈｔ受容体の修飾因子

Country Status (10)

Country Link
US (1) US7834010B2 (https=)
EP (1) EP1701951B1 (https=)
JP (1) JP4740152B2 (https=)
AT (1) ATE457309T1 (https=)
AU (1) AU2004303722B2 (https=)
CA (1) CA2551171C (https=)
DE (1) DE602004025508D1 (https=)
DK (1) DK1701951T3 (https=)
ES (1) ES2340855T3 (https=)
WO (1) WO2005061483A2 (https=)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0211230D0 (en) 2002-05-16 2002-06-26 Medinnova Sf Treatment of heart failure
WO2007007072A1 (en) * 2005-07-07 2007-01-18 Bio-Medisinsk Innovasjon As 5-htx modulators
CA2615611C (en) * 2005-07-22 2011-09-27 Pfizer Inc. Indazole derivatives
ITMI20062230A1 (it) * 2006-11-22 2008-05-23 Acraf Composto 2-alchil-indazolico procedimento per preparalo e composizione farmaceutica che lo comprende
MX2010004026A (es) 2007-10-19 2010-04-30 Boehringer Ingelheim Int Piperidino-dihidrotienopirimidinas sustituidas.
UA99927C2 (uk) * 2007-11-12 2012-10-25 Ацьенде Кимике Риуните Анджелини Франческо А.Чи.Р.А.Ф. С.П.А. Медикамент, який є активним при невропатичному болі
US8642772B2 (en) * 2008-10-14 2014-02-04 Sk Biopharmaceuticals Co., Ltd. Piperidine compounds, pharmaceutical composition comprising the same and its use
EP2400962B1 (de) 2009-02-27 2017-11-08 Boehringer Ingelheim International GmbH Arzneimittelkombinationen enthaltend pde4-inhibitoren und nsaids
GB0905641D0 (en) * 2009-04-01 2009-05-13 Serodus As Compounds
PT2512243E (pt) 2009-12-17 2016-06-08 Merck Sharp & Dohme Moduladores alostéricos positivos de recetor de quinolina amida m1
EP2555774B1 (de) 2010-04-08 2015-10-21 Boehringer Ingelheim International GmbH Arnzeimittelkombinationen enthaltend pde4-inhibitoren und ep4-rezeptor-antagonisten
CN105164119B (zh) 2013-03-20 2017-12-08 苏文生命科学有限公司 作为5‑ht4受体激动剂的5‑氨基‑喹啉‑8‑甲酰胺衍生物
MX368017B (es) * 2013-12-16 2019-09-13 Suven Life Sciences Ltd Compuestos de indazol como agonistas del receptor de 5-ht4.
EP3183232B1 (en) * 2014-08-22 2023-05-03 The Arizona Board of Regents on behalf of The University of Arizona Substituted 1-arylethyl-4-acylaminopiperidine derivatives as opioid/alpha-adrenoreceptor modulators and method of their preparation
CN111606837A (zh) * 2020-06-15 2020-09-01 千辉药业（安徽）有限责任公司 一种维格列汀的合成方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4494547A (en) 1981-03-30 1985-01-22 North Carolina Central University 2H-isoindolediones, their synthesis and use as radiosensitizers
WO1993018036A1 (en) 1992-03-12 1993-09-16 Smithkline Beecham Plc Condensed indole derivatives as 5ht4-receptor antagonists
RU2154064C2 (ru) 1994-09-27 2000-08-10 Жансен Фармасетика Н.В. N-замещенные пиперидинилбензоаты, их n-оксидные формы, фармацевтически приемлемые соли присоединения кислот и стереохимически изомерные формы, способы их получения, фармацевтическая композиция на их основе и промежуточный продукт
US6147093A (en) 1996-07-19 2000-11-14 Sepracor Inc. Methods for treating gastroesophageal reflux disease
US20010031751A1 (en) 1997-12-05 2001-10-18 Smithkline Beecham P.L.C. Pharmaceuticals
JPH11292846A (ja) 1998-02-10 1999-10-26 Hokuriku Seiyaku Co Ltd ベンズアミド誘導体及びそれを含有する医薬
JP3398111B2 (ja) * 1999-02-04 2003-04-21 北陸製薬株式会社 ベンズアミド誘導体及びそれを含有する医薬
AR022338A1 (es) * 1999-02-04 2002-09-04 Hokuriku Pharmaceutical Un compuesto de benzamida, medicamento que lo contiene, y uso para la manufactura de un medicamento para el tratamiento o prevencion de una enfermedad digestiva o para mejorar la movilidad del tracto gastrointestinal.
JP4584534B2 (ja) 2000-06-07 2010-11-24 アリックス セラピューティクス 胃食道逆流性疾患の治療のための材料
US6552004B1 (en) 2000-10-30 2003-04-22 Universite De Montreal Delivery system for entrapping charged macromolecules and a method for preparing same
US6598534B2 (en) 2001-06-04 2003-07-29 Raytheon Company Warhead with aligned projectiles
US6624163B2 (en) 2001-11-29 2003-09-23 Hoffman-La Roche Inc. Benzothiazole derivatives

Similar Documents

Publication Publication Date Title
JP2007516278A5 (https=)
MA28791B1 (fr) Derives de piperazine convenant pour le traitement de troubles gastro-intestinaux
BG66102B1 (bg) Карбаматни производни на арилалкиламини
ATE488496T1 (de) Histamin-3-rezeptorantagonisten
WO2005075436A3 (en) Novel inhibitors of glutaminyl cyclase
EP2096919A4 (en) SUBSTITUTED 2,3-DIHYDROIMIDAZO [1,2-C] CHINAZOLINE DERIVATIVES SUITABLE FOR THE TREATMENT OF HYPERPROLIFERATIVE DISORDER AND ANGIOGENIC RELATED DISEASES
WO2008050341A3 (en) Novel psychotropic agents having glutamate nmda activity
WO2007138431A3 (en) Azabicyclic ether histamine-3 antagonists
AR066641A1 (es) Amidas disustituidas para mejorar las respuestas sinapticas glutamatergicas
ATE438632T1 (de) Aryl-4-ethinylisoxazolderivate
NO20071326L (no) Kondenserte trisykliske derivater for behandling av psykotiske forstyrrelser
WO2006121560A3 (en) Methods and compositions for treatment of cns disorders
NO20082923L (no) Anvendelse av en CB1 antagonist for behandling av bivirkninger og negative symptomer pa schizofreni
NO20041833L (no) Heterocykliske forbindelser for anvendelse i behandlingen av forstyrrelser i urinveissystemet
IL190867A0 (en) 3-aryl-isoxazole-4-carbonyl-benzofuran derivatives
JP2007516193A5 (https=)
WO2005084655A8 (en) 1-aminocyclohexane derivatives for the treatment of agitation and other behavioral disorders, especially those associated with alzheimer’s disease
ATE400553T1 (de) 3,6-disubstituierte azabicyclo 3.1.0 - hexanderivative als antagonisten des muscarinrezeptors
ATE552251T1 (de) Thiophen- und furanverbindungen
ATE457309T1 (de) Modulatoren von peripheren 5-ht-rezeptoren
JP2005527477A5 (https=)
EP1799258A4 (en) PROCESS FOR TREATING ANGIOGENESIS
EP1814537A4 (en) MACROCYCLIC TERTIARY AMIN BETA SECRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER DISEASE
WO2006042137A3 (en) Methods for identifying parkinson's disease therapeutics
JP2008526706A5 (https=)